CO6450622A2 - Agentes antiinflamatorios como compuestos virostáticos - Google Patents
Agentes antiinflamatorios como compuestos virostáticosInfo
- Publication number
- CO6450622A2 CO6450622A2 CO11150236A CO11150236A CO6450622A2 CO 6450622 A2 CO6450622 A2 CO 6450622A2 CO 11150236 A CO11150236 A CO 11150236A CO 11150236 A CO11150236 A CO 11150236A CO 6450622 A2 CO6450622 A2 CO 6450622A2
- Authority
- CO
- Colombia
- Prior art keywords
- virus
- cdna
- dehydrogenase inhibitor
- dihydroorotate dehydrogenase
- single stranded
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Abstract
Un inhibidor de la dihidroorotato deshidrogenasa de fórmula (I)Donde X, A, L, Z1, Z2, R1, R2, R8, R3, Y, E, D, t, r, m, n y q son como se definen en las reivindicaciones, que puede usarse en el tratamiento o la mejora de una enfermedad o una condición médica causadas por una infección de virus de ADN de cadena doble (virus de ADNcd) , virus de ARN de cadena simple en el sentido positivo (virus de (+)ARNcs), virus de ARN de cadena simple en el sentido negativo (virus de (-)ARNcs), virus de ADN de cadena doble (ADNcd), virus de ARN de cadena simple que usan un intermediario de ADN para replicarse (virus de ARNcs-RT), virus de ADN de cadena doble que usan un intermediario de ARN durante la replicación del genoma (virus de ADNcd-RT), donde el inhibidor de la dihidroorotato deshidrogenasa no es leflunomida o un metabolito de ésta. También se revelan composiciones que comprenden dicho inhibidor de la dihidroorotato deshidrogenasa útiles en el tratamiento o mejoramiento de una enfermedad o condición médica causada por una infección viral.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17525509P | 2009-05-04 | 2009-05-04 | |
EP09159358 | 2009-05-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6450622A2 true CO6450622A2 (es) | 2012-05-31 |
Family
ID=43030861
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11150236A CO6450622A2 (es) | 2009-05-04 | 2011-11-04 | Agentes antiinflamatorios como compuestos virostáticos |
Country Status (16)
Country | Link |
---|---|
US (1) | US8354433B2 (es) |
EP (1) | EP2427186B1 (es) |
CN (1) | CN102458389A (es) |
AR (1) | AR076837A1 (es) |
AU (1) | AU2010244462B2 (es) |
CA (1) | CA2761130C (es) |
CO (1) | CO6450622A2 (es) |
ES (1) | ES2909738T3 (es) |
MX (1) | MX2011011733A (es) |
NZ (1) | NZ596014A (es) |
PE (1) | PE20120898A1 (es) |
SG (1) | SG175854A1 (es) |
TW (1) | TWI530286B (es) |
UY (1) | UY32605A (es) |
WO (1) | WO2010128050A2 (es) |
ZA (1) | ZA201108131B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA108760C2 (uk) * | 2010-07-01 | 2015-06-10 | Кальцієві солі сполуки як протизапальні, імуномодулюючі та антипроліферативні засоби | |
WO2013009678A2 (en) * | 2011-07-08 | 2013-01-17 | Indiana University Research And Technology Corporation | Compositions and methods for the treatment of norovirus infection |
CA2944570A1 (en) * | 2014-04-11 | 2015-10-15 | Panoptes Pharma Gmbh | Anti-inflammatory agents as virostatic compounds |
NZ725574A (en) * | 2014-05-08 | 2022-08-26 | Panoptes Pharma Ges M B H | Compounds for treating ophthalmic diseases and disorders |
TW201834649A (zh) | 2017-03-02 | 2018-10-01 | 新加坡商亞獅康私人有限公司 | 癌症療法 |
EP3965753A1 (en) * | 2019-05-07 | 2022-03-16 | Universität Hamburg | Dhodh inhibitors and their use as antiviral agents |
AU2021260040A1 (en) * | 2020-04-21 | 2022-11-17 | Immunic Ag | Vidofludimus for use in the treatment or prevention of viral diseases |
JP2023543969A (ja) * | 2020-08-31 | 2023-10-19 | アスラン ファーマスーティカルズ ピーティーイー エルティーディー | ウイルス感染の治療及び/又は予防 |
WO2022196236A1 (ja) * | 2021-03-18 | 2022-09-22 | 国立大学法人 鹿児島大学 | 抗薬剤耐性インフルエンザウイルス剤及び抗薬剤耐性インフルエンザウイルス剤の製造のための化合物の使用 |
WO2022214691A1 (en) | 2021-04-09 | 2022-10-13 | Immunic Ag | Deuterated dhodh inhibitors |
EP4119138A1 (en) * | 2021-07-12 | 2023-01-18 | Universität Hamburg | Dhodh inhibitors and their use as antiviral agents |
TW202332433A (zh) | 2021-12-23 | 2023-08-16 | 德商埃慕尼克股份公司 | 含羧酸生物電子等排體之dhodh抑制劑 |
WO2023168176A1 (en) * | 2022-03-01 | 2023-09-07 | Kiora Pharmaceuticals Gmbh | Salts of a dihydroorotate dehydrogenase (dhod) inhibitor |
US20230286938A1 (en) * | 2022-03-09 | 2023-09-14 | Kiora Pharmaceuticals Gmbh | Polymorphs of a dihydroorotate dehydrogenase (dhod) inhibitor |
WO2023232884A1 (en) | 2022-06-01 | 2023-12-07 | Immunic Ag | Treatment of ulcerative colitis comprising vidofludimus or a pharmaceutically acceptable salt thereof |
CN116803387A (zh) * | 2023-07-25 | 2023-09-26 | 徐州医科大学 | Vidofludimus在制备戊型肝炎药物中的应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19860802A1 (de) * | 1998-12-30 | 2000-10-26 | Virgene Pharmaceuticals Ag | Herstellung eines Mittels gegen Hepatitis B-, HI-, Paramyxo und Orthomyxo-Viren |
EP1237546A2 (en) * | 1999-10-01 | 2002-09-11 | Institute of Molecular and Cell Biology | Dihydroorotate dehydrogenase inhibitors for the treatment of viral-mediated diseases |
WO2003006424A1 (en) * | 2001-07-10 | 2003-01-23 | 4Sc Ag | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
EP1581478A1 (en) * | 2002-12-23 | 2005-10-05 | 4Sc Ag | Dhodh-inhibitors and method for their identification |
US7071355B2 (en) * | 2002-12-23 | 2006-07-04 | 4 Sc Ag | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
EP1581477B1 (en) * | 2002-12-23 | 2009-12-02 | 4Sc Ag | Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents |
WO2005018330A1 (en) * | 2003-08-18 | 2005-03-03 | Pharmasset, Inc. | Dosing regimen for flaviviridae therapy |
ES2319596B1 (es) | 2006-12-22 | 2010-02-08 | Laboratorios Almirall S.A. | Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico. |
UY31272A1 (es) | 2007-08-10 | 2009-01-30 | Almirall Lab | Nuevos derivados de ácido azabifenilaminobenzoico |
-
2010
- 2010-04-30 TW TW099113936A patent/TWI530286B/zh not_active IP Right Cessation
- 2010-05-03 US US12/772,470 patent/US8354433B2/en active Active
- 2010-05-03 UY UY0001032605A patent/UY32605A/es not_active Application Discontinuation
- 2010-05-04 PE PE2011001900A patent/PE20120898A1/es not_active Application Discontinuation
- 2010-05-04 MX MX2011011733A patent/MX2011011733A/es active IP Right Grant
- 2010-05-04 CA CA2761130A patent/CA2761130C/en not_active Expired - Fee Related
- 2010-05-04 SG SG2011080488A patent/SG175854A1/en unknown
- 2010-05-04 ES ES10715894T patent/ES2909738T3/es active Active
- 2010-05-04 AU AU2010244462A patent/AU2010244462B2/en not_active Ceased
- 2010-05-04 WO PCT/EP2010/056042 patent/WO2010128050A2/en active Application Filing
- 2010-05-04 NZ NZ596014A patent/NZ596014A/xx not_active IP Right Cessation
- 2010-05-04 CN CN2010800290606A patent/CN102458389A/zh active Pending
- 2010-05-04 AR ARP100101509A patent/AR076837A1/es unknown
- 2010-05-04 EP EP10715894.1A patent/EP2427186B1/en active Active
-
2011
- 2011-11-03 ZA ZA2011/08131A patent/ZA201108131B/en unknown
- 2011-11-04 CO CO11150236A patent/CO6450622A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
TW201043228A (en) | 2010-12-16 |
NZ596014A (en) | 2013-06-28 |
WO2010128050A2 (en) | 2010-11-11 |
PE20120898A1 (es) | 2012-08-24 |
UY32605A (es) | 2010-12-31 |
US8354433B2 (en) | 2013-01-15 |
CA2761130A1 (en) | 2010-11-11 |
EP2427186B1 (en) | 2022-01-12 |
CA2761130C (en) | 2017-03-28 |
MX2011011733A (es) | 2012-02-01 |
CN102458389A (zh) | 2012-05-16 |
AU2010244462B2 (en) | 2015-07-02 |
AU2010244462A1 (en) | 2011-11-17 |
SG175854A1 (en) | 2011-12-29 |
WO2010128050A3 (en) | 2011-05-05 |
ZA201108131B (en) | 2012-07-25 |
US20100280081A1 (en) | 2010-11-04 |
AR076837A1 (es) | 2011-07-13 |
EP2427186A2 (en) | 2012-03-14 |
ES2909738T3 (es) | 2022-05-10 |
TWI530286B (zh) | 2016-04-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6450622A2 (es) | Agentes antiinflamatorios como compuestos virostáticos | |
EA201690497A3 (ru) | Композиции и способы ингибирования экспрессии генов вируса гепатита в | |
ECSP10010618A (es) | Análogos carba - nucleósidos para tratamiento antiviral | |
CR20110605A (es) | Compuestos heterocíclicos antivirales | |
EA026341B9 (ru) | Кристаллическая форма нуклеозидфосфорамидата | |
CO6331439A2 (es) | 1-2 bicíclicos pirimidinona carboxamida como inhibidores de la integrasa del virus de inmunodeficiencia humana | |
EA201391519A1 (ru) | 2'-замещенные нуклеозидные производные и способы их применения для лечения вирусных заболеваний | |
PE20230684A1 (es) | Analogos de carba-nucleosidos sustituidos con 2'-fluoro como inhibidores de la arn polimerasa | |
CL2014000612A1 (es) | Compuestos derivados de prolinas macrociclicas, inhibidores de las proteasas de serina del virus de la hepatitis c (vhc); composicion farmaceutica que los comprende; y su uso para tratar una infeccion viral tal como la infeccion por el virus de la hepatitis c (vhc). | |
TR201908127T4 (tr) | Hbv tedavisi. | |
ECSP13012417A (es) | Derivados de ácido napht-2-ilacético para tratar sida | |
NI201000174A (es) | Nuevos inhibidores macrocíclicos de la replicación del virus de la hepatitis c. | |
AR076570A1 (es) | Moleculas de union humanas capaces de neutralizar el virus de la influenza h3n2 y usos de las mismas | |
AR084237A1 (es) | Metodos para tratar virus de hepatitis c (hcv), composicion | |
BR112014003919A2 (pt) | métodos e meios para modificar um genoma de planta | |
EA201100390A1 (ru) | Соединения для лечения гепатита с | |
EA201491180A1 (ru) | 4'-азидо,3'-фторзамещенные производные нуклеозидов в качестве ингибиторов репликации рнк вируса гепатита с | |
UY32793A (es) | Compuestos inhibidores de los virus flaviviridae, composición farmacéutica que los contiene y sus usos | |
UA108221C2 (uk) | Похідні тіофен-2-карбонової кислоти як інгібітори вірусів flaviviridae | |
CO6382185A2 (es) | Compuestos nucleosidos antivirales | |
CL2008003819A1 (es) | Compuestos derivados del acido 2-cetoamino benzoico sustituido, inhibidores del virus de la hepatitis c; composicion farmaceutica; y su uso en el tratamiento de una infeccion por vhc. | |
CL2008002291A1 (es) | Compuestos derivados del acido 4-fluor-benzoico, inhibidores de la polimerasa hcv, composicion farmaceutica, kit farmaceutico y su uso para el tratamiento de una infeccion viral por hepatitis c. | |
BR112014006559A2 (pt) | derivados do ácido betulínico com atividade antiviral | |
UY34066A (es) | Inhibidores del virus de la hepatitis c | |
AR114551A1 (es) | COMPOSICIONES DE AGENTES DE ARNhd CONTRA EL VIRUS DE HEPATITIS B (HBV) Y MÉTODOS PARA SU USO |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Application refused |